Investments That Change The World

CREATING VALUE OUT OF

SCIENTIFIC MILESTONES

World class discoveries in bioscience provide the fundamental basis for pharmaceuticals and devices that global populations of patients, hospitals and healthcare providers rely on every day.

Innovations with real world potential to create a disease-free world are becoming more urgent than ever before.

Our experts at The iQ Group Global find, fund and develop life-changing bioscience assets.

With four direct listings on two Australian exchanges and expertise in private banking, financial planning and equities analysis, The iQ Group Global creates opportunities to bring unique innovations to global healthcare markets.

Get in touch, or register below for opportunities.

Our listed companies

iQX raises the capital needed to fund scientific development of life science assets.

NSX:iQX

The iQnovate team of scientific experts manage asset IP, and create asset development strategies.

NSX:iQN

iQ3 provides corporate advisory and deal structuring services for the life science industry.

ASX:iQ3

FarmaForce, a Contract Sales Organisation (CSO), provides expert sales solutions to take life science assets to healthcare markets.

ASX:FFC

Partner with us

Nick Dinopoulos

Director of Capital Access and Investor Engagement

Nick Dinopoulos

Director of Capital Access and Investor Engagement

As Director, Capital Access and Investor Engagement at The IQ Group Global, Nick is responsible for formulating The Group’s overarching strategy for capital raising and investor engagement, and leading the teams responsible for executing this strategy.
Prior to joining The iQ Group Global, Nick has held senior leadership positions across a broad range of industry sectors including financial services, FMCG, Oil and Gas, where he led sales and operations departments of one thousand staff.

Con Tsigounis

Executive Head of Investor Relations, Private Wealth

Con Tsigounis

Executive Head of Investor Relations, Private Wealth

A founding member of The iQ Group Global, Con is responsible for executing The Group’s investor relations and capital raising strategy.
With 30 years’ experience in investor relations and private wealth, Con serves as Executive Director on boards of iQnovate Ltd and FarmaForce Ltd. Con has been instrumental in the growth of the company, successfully listing four companies within The iQ Group Global on the ASX and NSX.

Lei Xu

Director of Structured Investment Products

Lei Xu

Director of Structured Investment Products

As Director of Structured Investment Products for our Investment Banking function, Lei is responsible for structuring the equity investment offerings for capital raising through equity capital markets. Also, Lei works closely with The Group’s capital access and corporate advisory functions to create structured financial instruments for funding the development of novel biotech assets.

Lei holds an MBA from AGSM, and is Fellow of the Association of Chartered Certified Accountants. Lei previously served as Director of APAC for The iQ Group Global.

Michael Baker

Head of Distribution, Capital Access

Michael Baker

Head of Distribution, Capital Access

Michael is responsible for the wholesale distribution of The iQ Group Global’s investment opportunities, working with financial planners, private banks, family offices and industry superannuation.
Michael has more than 20 years’ experience in the financial services industry, including wealth management, funds management and investment banking, across global financial institutions, regional enterprises and local start-ups.